Interestingly, we discovered that LINC02195 was up-regulated in the low-risk group and correlated to a favorable prognosis of BC patients in this research, suggesting that LINC02195 may act as a tumor suppressor and plays an important role in the immunity of BC. The gene discussed is LINC02195; the disease is breast cancer.